ArticleFrontiers in immunology2026
Iodine-125 brachytherapy triggers immunogenic cell death and potentiates anti-PD-L1 immunotherapy in bone metastatic triple-negative breast cancer.
Min Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.